HK1244006A1 - Parp抑制劑的結晶形式 - Google Patents
Parp抑制劑的結晶形式Info
- Publication number
- HK1244006A1 HK1244006A1 HK18103530.1A HK18103530A HK1244006A1 HK 1244006 A1 HK1244006 A1 HK 1244006A1 HK 18103530 A HK18103530 A HK 18103530A HK 1244006 A1 HK1244006 A1 HK 1244006A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- crystalline forms
- parp inhibitors
- parp
- inhibitors
- crystalline
- Prior art date
Links
- 239000012661 PARP inhibitor Substances 0.000 title 1
- 229940121906 Poly ADP ribose polymerase inhibitor Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/08—Acetic acid
- C07C53/10—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/06—Glycolic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462084652P | 2014-11-26 | 2014-11-26 | |
PCT/US2015/062572 WO2016086080A1 (en) | 2014-11-26 | 2015-11-25 | Crystalline forms of parp inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1244006A1 true HK1244006A1 (zh) | 2018-07-27 |
Family
ID=54849709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18103530.1A HK1244006A1 (zh) | 2014-11-26 | 2018-03-13 | Parp抑制劑的結晶形式 |
Country Status (13)
Country | Link |
---|---|
US (1) | US10150772B2 (zh) |
EP (1) | EP3224259A1 (zh) |
JP (1) | JP2017535564A (zh) |
KR (1) | KR20170088894A (zh) |
CN (1) | CN107207511A (zh) |
AU (1) | AU2015353549A1 (zh) |
BR (1) | BR112017010588A2 (zh) |
CA (1) | CA2967828A1 (zh) |
HK (1) | HK1244006A1 (zh) |
IL (1) | IL252162A0 (zh) |
MX (1) | MX2017006679A (zh) |
RU (1) | RU2017120655A (zh) |
WO (1) | WO2016086080A1 (zh) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060276497A1 (en) | 2000-05-09 | 2006-12-07 | Cephalon, Inc. | Novel multicyclic compounds and the use thereof |
US7122679B2 (en) | 2000-05-09 | 2006-10-17 | Cephalon, Inc. | Multicyclic compounds and the use thereof |
AR063869A1 (es) * | 2006-11-20 | 2009-02-25 | Cephalon Inc | Metodo de radiosensibilizacion de tumores usando un agente radiosensibilizante |
MX2012002456A (es) * | 2009-08-26 | 2012-05-08 | Cephalon Inc | Nuevas formas de un compuesto multiciclico. |
-
2015
- 2015-11-25 AU AU2015353549A patent/AU2015353549A1/en not_active Abandoned
- 2015-11-25 WO PCT/US2015/062572 patent/WO2016086080A1/en active Application Filing
- 2015-11-25 CN CN201580063386.3A patent/CN107207511A/zh active Pending
- 2015-11-25 RU RU2017120655A patent/RU2017120655A/ru not_active Application Discontinuation
- 2015-11-25 CA CA2967828A patent/CA2967828A1/en not_active Abandoned
- 2015-11-25 JP JP2017527299A patent/JP2017535564A/ja active Pending
- 2015-11-25 BR BR112017010588-8A patent/BR112017010588A2/pt not_active Application Discontinuation
- 2015-11-25 US US15/529,883 patent/US10150772B2/en not_active Expired - Fee Related
- 2015-11-25 KR KR1020177016523A patent/KR20170088894A/ko unknown
- 2015-11-25 MX MX2017006679A patent/MX2017006679A/es unknown
- 2015-11-25 EP EP15808507.6A patent/EP3224259A1/en not_active Withdrawn
-
2017
- 2017-05-08 IL IL252162A patent/IL252162A0/en unknown
-
2018
- 2018-03-13 HK HK18103530.1A patent/HK1244006A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP3224259A1 (en) | 2017-10-04 |
RU2017120655A3 (zh) | 2018-12-14 |
US20170267683A1 (en) | 2017-09-21 |
CN107207511A (zh) | 2017-09-26 |
AU2015353549A1 (en) | 2017-06-01 |
WO2016086080A1 (en) | 2016-06-02 |
KR20170088894A (ko) | 2017-08-02 |
IL252162A0 (en) | 2017-07-31 |
JP2017535564A (ja) | 2017-11-30 |
BR112017010588A2 (pt) | 2018-05-15 |
MX2017006679A (es) | 2018-07-06 |
RU2017120655A (ru) | 2018-12-14 |
US10150772B2 (en) | 2018-12-11 |
CA2967828A1 (en) | 2016-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288519B1 (en) | inhibitors of ret | |
IL251584B (en) | Dihydropyrrolopyridines ror–gamma inhibitors | |
HK1245247A1 (zh) | 溴結構域的抑制劑 | |
IL246902B (en) | Dihydropyrrolopyridine ror–gamma inhibitors | |
ZA201604272B (en) | Inhibitors of glutaminase | |
AP2016009496A0 (en) | Substituted spirocydic inhibitors of autotaxin | |
GB201521059D0 (en) | Inhibitors of metallo-beta-lactamases | |
EP3494971C0 (en) | ERK INHIBITOR SALTS | |
SI3380554T2 (sl) | Kristalne oblike per-kloro-gama-ciklodekstrinov | |
PT3113773T (pt) | Formas cristalinas do grapiprant | |
HK1244274A1 (zh) | C21h22ci2n4o2的晶型 | |
PL3529236T3 (pl) | Krystaliczne formy erawacykliny | |
IL253479A0 (en) | Crystalline forms of efinconazole | |
HK1244006A1 (zh) | Parp抑制劑的結晶形式 |